Both creatine pyruvate and creatine citrate beat placebo in a 28-day trial. But only one of them kept muscle force elevated through ten rounds of all-out effort while the other faded. Before you swap your tub of creatine for the fancier-sounding option, read the fine print, because the study left out the one comparison that matters most.
What the Study Did
This 2008 paper in the Journal of the International Society of Sports Nutrition (Jäger and colleagues) was a double-blind, placebo-controlled, randomized trial in healthy young athletes. Forty-nine participants were split into three groups:
- Creatine pyruvate (Cr-Pyr): 5 g/day, n = 16
- Creatine citrate (Cr-Cit): 5 g/day, n = 16
- Placebo: 5 g/day, n = 17
Everyone supplemented for 28 days. Before and after, they did an intermittent handgrip test of maximal intensity: ten 15-second all-out intervals, each followed by 45 seconds of rest. Researchers tracked power, force, contraction velocity, relaxation velocity, and oxygen consumption during the rest periods.
What It Found: The Actual Numbers
Both alternative forms worked against placebo. The reported results were:
- Mean power over all intervals: increased with Cr-Pyr (p < 0.001) and Cr-Cit (p < 0.01).
- Contraction velocity: increased with Cr-Pyr (p < 0.001) and Cr-Cit (p < 0.01).
- Force with Cr-Cit: higher than placebo in the first and second intervals (p < 0.01). The effect shrank over time and was no longer significant by the sixth and ninth intervals.
- Force with Cr-Pyr: significantly increased in all intervals (p < 0.001).
- Relaxation velocity: only Cr-Pyr produced a significant increase (p < 0.01).
- Oxygen consumption during rest periods: significantly higher with Cr-Pyr (p < 0.05). Cr-Cit and placebo showed no significant improvement.
The pattern is what makes this study notable. Citrate gave a strong start that faded. Pyruvate held force up across the whole set and also improved how quickly the muscle relaxed between contractions. The authors speculated that pyruvate might benefit endurance through enhanced aerobic metabolism, but that is an interpretation of the oxygen data, not a demonstrated endurance result.
The Catch: What This Study Can't Tell You
There was no creatine monohydrate group. This is the biggest limitation. The study shows that pyruvate and citrate beat placebo. It does not show that either beats monohydrate, matches it, or is worth paying more for. Nothing here dethrones the form with the longest research track record.
Other limitations matter too:
- Dose by weight, not by creatine. Both groups took 5 g of compound per day. Creatine pyruvate is roughly 60% creatine and creatine citrate roughly 40%. Five grams of either delivers less actual creatine than 5 g of monohydrate. The pyruvate and citrate groups also did not receive the same amount of creatine, so a "pyruvate beats citrate" conclusion is muddied by dose.
- A narrow test. Handgrip exercise uses a small muscle group. It says little about squats, sprints, or a full training session.
- Small groups. Roughly 16 people per supplement arm is modest, and the abstract reports significance levels rather than effect sizes.
- Industry ties. Co-authors include supplement-industry researchers (including Jäger and Purpura). That doesn't invalidate the data, but independent replication would strengthen it.
- One short window. Twenty-eight days says nothing about long-term effects.
Which Creatine Form Should You Actually Use?
Monohydrate remains the evidence-backed default. It has by far the deepest research base, and it is usually the cheapest. Nothing in this paper changes that.
Pyruvate and citrate are reasonable to consider only if you have a specific reason, such as a monohydrate product you dislike or a personal preference. If you go that route, the study gives you these reference points:
- Dose used: 5 g/day of the compound, taken daily for 28 days.
- Timing: The study did not test timing, so there is no data-backed "best time" here. Consistency is the sensible approach.
- Form: Pyruvate looked better than citrate for sustaining force across repeated efforts. That is a single small study, not a verdict.
- Math your dose: Because creatine content per gram differs, don't assume a 5 g scoop of any form equals 5 g of creatine.
Who It's For, Who Should Skip It
Worth considering:
- Athletes in repeated-effort sports (intervals, rounds, sets with short rests) who are curious about alternatives and understand the evidence is thin.
- People who have already tried monohydrate and have a personal reason to switch.
Probably skip:
- Anyone who wants the proven, budget-friendly option. Buy monohydrate.
- Anyone expecting that a pricier form means better results. This study doesn't support that.
- People with kidney or other medical conditions, or who take medications. Talk to a clinician before using any creatine product.
The Bottom Line
In this trial, both creatine pyruvate and creatine citrate improved high-intensity handgrip performance over placebo. Pyruvate showed the more durable force benefit and was the only form to improve relaxation velocity and resting oxygen consumption. It's an interesting signal, but one small, short, industry-linked study without a monohydrate arm can't tell you which creatine form is best. Until head-to-head data say otherwise, monohydrate stays the benchmark and the safe choice for most lifters.
